GlassScriptPhysician profile
Stephany Manurung
NPI 1669065660
$3,785.25
in general payments reported to CMS, 2019-2025
14 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.50 · 2022: $1,316 · 2023: $1,202 · 2024: $960 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $746.20 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $708.92 | 2021-2025 | Rexulti, Abilify Mycite, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $595.05 | 2022-2024 | Trintellix |
| Lundbeck LLC | $462.07 | 2022-2025 | Rexulti, Brintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $393.09 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $311.50 | 2022-2025 | Auvelity |
| Almatica Pharma LLC | $158.45 | 2022-2024 | Loreev Xr, Sertraline Hcl |
| Janssen Pharmaceuticals, INC | $102.39 | 2021-2022 | |
| Alkermes, INC. | $87.73 | 2021-2022 | |
| Corium, LLC | $83.33 | 2022-2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $78.22 | 2022 | |
| Boston Scientific Corporation | $20.63 | 2024 | |
| Idorsia Pharmaceuticals US INC | $20.43 | 2023 | Quviviq |
| Biogen, INC. | $17.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephany Manurung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.